Method of formulating IGF-I with growth hormone
First Claim
1. A process for preparing a formulation comprising mixing an IGF-I-containing composition comprising about 2-20 mg/ml of IGF-I, about 2-50 mg/ml of an osmolyte, about 1-15 mg/ml of a stabilizer, and a buffered solution at about pH. 5-5.5 with a buffered solution comprising growth hormone at pH about 6 in a dose (mg) ratio of from about 2:
- 1 to 100;
1 IGF-I;
growth hormone up to a dose no greater than about 5 mg/ml of growth hormone.
0 Assignments
0 Petitions
Accused Products
Abstract
A formulation for IGF-I is disclosed that is useful in treating hyperglycemic disorders and, in combination with growth hormone, in enhancing growth of a mammal. Also disclosed is a process for preparing a formulation of growth hormone and IGF-I from the IGF-I formulation. The IGF-I formulation comprises about 2-20 mg/ml of IGF-I, about 2-50 mg/ml of an osmolyte, about 1-15 mg/ml of a stabilizer, and a buffered solution at about pH 5-5.5, optionally with a surfactant.
-
Citations
7 Claims
-
1. A process for preparing a formulation comprising mixing an IGF-I-containing composition comprising about 2-20 mg/ml of IGF-I, about 2-50 mg/ml of an osmolyte, about 1-15 mg/ml of a stabilizer, and a buffered solution at about pH. 5-5.5 with a buffered solution comprising growth hormone at pH about 6 in a dose (mg) ratio of from about 2:
- 1 to 100;
1 IGF-I;
growth hormone up to a dose no greater than about 5 mg/ml of growth hormone. - View Dependent Claims (2, 3, 4, 5, 6, 7)
- 1 to 100;
Specification